Precision BioSciences, Inc.
DTIL
$7.43
$0.131.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -68.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -68.31% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -68.31% | |||
| SG&A Expenses | -0.53% | -5.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.78% | -8.22% | |||
| Operating Income | -111.14% | -172.55% | |||
| Income Before Tax | -77.06% | -195.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -77.06% | -195.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -77.06% | -191.60% | |||
| EBIT | -111.14% | -172.55% | |||
| EBITDA | -115.45% | -168.28% | |||
| EPS Basic | -68.69% | -170.84% | |||
| Normalized Basic EPS | -99.29% | -160.91% | |||
| EPS Diluted | -68.37% | -171.43% | |||
| Normalized Diluted EPS | -99.29% | -161.29% | |||
| Average Basic Shares Outstanding | 4.96% | 29.31% | |||
| Average Diluted Shares Outstanding | 4.96% | 28.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||